SLC13A5 Citrate Transporter Disorder (SLC13A5 Deficiency, SLC13A5 Epilepsy, Development, and Epileptic Encephalopathy DEE25, OMIM #615905) is a rare pediatric neurodevelopmental disorder characterized by the onset of seizures in the neonatal period, global developmental delay, limited verbal communication abilities, and motor impairments, including dystonia, hypotonia, and difficulty walking [1,2]. The gene discussed is SLC13A5; the disease is Dystonia.